Langerhans cell histiocytosis natural history: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) Created page with "{{Langerhans cell histiocytosis}} {{CMG}} ==Prognosis== Excellent for single foci disease. <br />With multi-focal disease 60% have a chronic course, 30% achieve remission and..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Langerhans cell histiocytosis}} | {{Langerhans cell histiocytosis}} | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | |||
==Prognosis== | ==Prognosis== | ||
Revision as of 19:09, 13 September 2012
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis natural history On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis natural history |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Prognosis
Excellent for single foci disease.
With multi-focal disease 60% have a chronic course, 30% achieve remission and mortality is up to 10%[1].